Chemotherapy for head and neck tumours. Observations on a twelve-month study.
This paper describes a multiagent protocol of chemotherapy suitable for head and neck cancer which has been used at King's College Hospital since 1974. It studies a twelve month period in which 30 patients received chemotherapy and offers details of eight patients who were free of tumour from two to twelve months after completing the treatment. No statistical evaluation is attempted as the follow-up period is so short and the clinical material so diverse.
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002648:Child; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D008727:Methotrexate